Zdrowie i gospodarka · 03/10/2018

FDA Releases Final Guidance on Pediatric Studies for Atopic Dermatitis Treatments

The US Food and Drug Administration (FDA) has issued a final guidance document outlining its recommendations for the timing of pediatric studies during the development of systemic drugs for atopic dermatitis, a condition affecting millions of children worldwide.